John Maraganore, a well-known figure in the biotech industry, recently discussed his involvement in the innovative RNAi startup, City Therapeutics, on the latest episode of STAT’s biotech podcast, “The Readout LOUD.” Maraganore shared insights into the startup, the recent Nobel Prize awards, and his own achievements in the field.
One of the topics covered in the podcast was the interest of longevity-minded tech individuals in controversial CRISPR scientist He Jiankui. Megan Molteni, a reporter at STAT, delved into the connection between a crypto investor and He Jiankui, known for his work on CRISPR technology.
For those looking to understand why a crypto investor would be interested in CRISPR technology, Molteni’s article provides valuable insights. Additionally, the podcast highlighted the groundbreaking work in AI protein design that led to a Nobel Prize win, showcasing the intersection of technology and biotech innovation.
Listeners were also encouraged to explore more about City Therapeutics, the startup Maraganore is involved with, and to purchase tickets for the upcoming STAT Summit in Boston. The podcast serves as a platform for industry professionals and enthusiasts to stay updated on the latest developments in biotech and venture capital.
As the biotech and venture capital reporter at STAT, Allison DeAngelis provides in-depth coverage of scientific innovation and financial investments in the industry. Alongside Adam Feuerstein, a senior writer and biotech columnist, she co-hosts The Readout LOUD podcast, offering a unique perspective on the trends shaping the biotech landscape.
With a focus on drug development, business strategies, and market trends, The Readout LOUD podcast serves as a valuable resource for those interested in the intersection of science, technology, and finance. By featuring industry experts like John Maraganore and exploring cutting-edge topics like AI protein design and CRISPR technology, the podcast offers an engaging and informative platform for listeners.
Whether you’re a seasoned professional in the biotech field or simply curious about the latest advancements in science and technology, tuning into The Readout LOUD podcast can provide valuable insights and perspectives. Stay informed, stay engaged, and stay inspired by joining the conversation at the crossroads of biotech innovation and venture capital investment.
